Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) is Now Treatable : IMULAN BioTherapeutics



				NEW : LTCI is Now Available in 3-Dose Pack



				DOWNLOAD: Lymphocyte T-Cell Immunomodulator Brochure



					Lymphocyte T-Cell Immunomodulator (LTCI) is the first and only approved treatment aid* in the United States for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) infections.
							IMULAN is focused on providing innovative solutions for complex animal diseases. Our policy is to provide veterinarians access to conditionally approved products for diseases, such as FeLV and FIV, where no current approved therapy is available.

	*Lymphocyte T-Cell Immunomodulator has received a conditional license from the United States Department of Agriculture. Additional efficacy and potency studies are in progress. LTCI is manufactured by T-Cyte Therapeutics, Inc. and is exclusively distributed by IMULAN BioTherapeutics, LLC.




		site map
© 2008 IMULAN BioTherapeutics, LLC \| terms \| privacy	glossary